BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 595495)

  • 1. [Effect of new 2-propinylamine derivatives on mitochondrial monoamine oxidase activity].
    Shatemirova KK; Davydova GA; Verevkina IV; Tichilkin AI
    Vopr Med Khim; 1977; 23(5):609-18. PubMed ID: 595495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of the activity of monoamine oxidases type A and B by derivatives of 2-propynylamine].
    Shatemirova KK; Verevkina IV; Gorkin VZ
    Vopr Med Khim; 1977; 23(2):220-6. PubMed ID: 883159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
    Severina IS; Klimova GI; Nersisian AA
    Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Baygon (2-isopropoxyphenyl-N-methyl carbamate) activation of enzymatic deamination of 2-phenyl-ethylamine].
    Zeĭnalov TA
    Vopr Med Khim; 1985; 31(5):60-4. PubMed ID: 4090367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Kinetics of the inhibition of mitochondrial monoamine oxidases A and B from rat liver by 1-(indolyl-3)isopropylmethylpropargylamine].
    Gridneva LI; Dolicheva IN; Gorkin VZ; Smushkevich IuI; Suvorov NN
    Biokhimiia; 1983 Jul; 48(7):1122-8. PubMed ID: 6615922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Properties of intestinal monoamine oxidase in the rat].
    Verevkina IV; Asnina VV; Gorkin VZ
    Vopr Med Khim; 1982; 28(2):88-93. PubMed ID: 7080482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monoamine oxidase inhibition by pyrrole quinoline derivatives].
    Moskvitina TA; Shabunova VP; Akhvlediani RN; Suvorov NN
    Biokhimiia; 1988 May; 53(5):714-20. PubMed ID: 3167119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selective inhibition by pyrazidol of monoamine oxidase type A in different human and animal tissues].
    Verevkina IV; Asnina VV; Gorkin VZ; Mashkovskiĭ MD
    Vopr Med Khim; 1983; 29(5):118-23. PubMed ID: 6649522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat.
    Egashira T; Ekstedt B; Kinemuchi H; Wiberg A; Oreland L
    Med Biol; 1976 Aug; 54(4):272-7. PubMed ID: 957813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of solubilization by methylethyl ketone of mitochondrial monoamine oxidase of the rat liver on the kinetic properties of the enzyme].
    Volkovitskaia OE; Severina IS
    Biokhimiia; 1984 Sep; 49(9):1502-9. PubMed ID: 6518192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of catalytic properties of mink and rat liver monoamine oxidase].
    Iagodina OV
    Zh Evol Biokhim Fiziol; 2008; 44(6):570-6. PubMed ID: 19198157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
    Gol'dina OA; Zagorevskiĭ VA; Lopatina KI; Sokolova TV; Gankina EM
    Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].
    Deverina IS
    Biokhimiia; 1980 Oct; 45(10):1897-908. PubMed ID: 6786369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steric influence on inhibition of monoamine oxidase forms by 2,3-dichloro-alpha-methylbenzylamine.
    Fuller RW; Hemrick SK
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):199-202. PubMed ID: 663404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of a new antiparkinsonian drug himantane on monoamine oxidase activity].
    Val'dman EA; Voronina TA; Aksenova LN; Buneeva OA; Medvedev AE
    Eksp Klin Farmakol; 2003; 66(5):3-5. PubMed ID: 14650204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of the "B form" of monoamine oxidase.
    Magyar K; Knoll J
    Pol J Pharmacol Pharm; 1977; 29(3):233-46. PubMed ID: 887501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of oxygen and drugs on monoamine oxidase in the dog liver].
    Kimura K
    Nihon Yakurigaku Zasshi; 1983 Apr; 81(4):305-13. PubMed ID: 6884886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.
    Inoue H; Castagnoli K; Van Der Schyf C; Mabic S; Igarashi K; Castagnoli N
    J Pharmacol Exp Ther; 1999 Nov; 291(2):856-64. PubMed ID: 10525109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.